Notice of Allowance of Patent in US

7th June 2021

Nuformix plc (LSE: NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing,  is pleased to announce that it has received a Notice of Allowance for a U.S. National Phase Patent Application No. 17/051,592 entitled “CRYSTALLINE TRANILAST SALTS AND THEIR PHARMACEUTICAL USE”. Download News

Back to all News